Nuveen Asset Management Portfolio holdings
Nuveen Asset Management, founded in 1898 by John Nuveen and headquartered in Chicago, Illinois, is a leading global investment manager and subsidiary of TIAA, overseeing hundreds of billions in assets with a focus on fixed income, equities, and sustainable investing. Initially known for municipal bonds, Nuveen has expanded into a broad range of strategies, including mutual funds, ETFs, closed-end funds, and private capital solutions, serving institutional investors, financial advisors, and individuals. The firm emphasizes income-generating investments and ESG (environmental, social, governance) integration, leveraging its deep research capabilities and a century-long legacy in the bond market. With a strong presence in North America and growing international reach, Nuveen blends tradition with innovation to meet diverse client needs in the evolving investment landscape.
Top Buys
| 1 |
AbbVie
ABBV
|
+$683M |
| 2 |
Meta Platforms (Facebook)
META
|
+$553M |
| 3 |
RTX Corp
RTX
|
+$450M |
| 4 |
Eli Lilly
LLY
|
+$389M |
| 5 |
T-Mobile US
TMUS
|
+$386M |
Top Sells
| 1 |
Amazon
AMZN
|
+$945M |
| 2 |
Microsoft
MSFT
|
+$572M |
| 3 |
Gilead Sciences
GILD
|
+$467M |
| 4 |
Merck
MRK
|
+$368M |
| 5 |
Intel
INTC
|
+$361M |
Sector Composition
| 1 | Technology | 23.64% |
| 2 | Healthcare | 14.1% |
| 3 | Financials | 12.39% |
| 4 | Consumer Discretionary | 12.19% |
| 5 | Communication Services | 9.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
HTO
1651
H2O America Common Stock
HTO
$1.75B
| $7.85M | ﹤0.01% |
138,196
-8,091
| -6% | -$460K |
|
1652
Cactus
WHD
$2.74B
| $7.83M | ﹤0.01% |
379,712
+117,925
| +45% | +$2.43M |
|
|
VRTU
1653
DELISTED
Virtusa Corporation
VRTU
| $7.83M | ﹤0.01% |
241,053
+8,000
| +3% | +$260K |
|
1654
Trustmark
TRMK
$2.43B
| $7.82M | ﹤0.01% |
319,056
+29,207
| +10% | +$716K |
|
1655
First Citizens BancShares
FCNCA
$25.5B
| $7.82M | ﹤0.01% |
19,312
-361
| -2% | -$146K |
|
1656
Supernus Pharmaceuticals
SUPN
$2.55B
| $7.81M | ﹤0.01% |
328,797
+12,943
| +4% | +$307K |
|
1657
ICU Medical
ICUI
$3.22B
| $7.8M | ﹤0.01% |
42,340
+1,305
| +3% | +$241K |
|
1658
Health Catalyst
HCAT
$220M
| $7.77M | ﹤0.01% |
266,256
+121,554
| +84% | +$3.55M |
|
1659
EverQuote
EVER
$896M
| $7.76M | ﹤0.01% |
133,353
+22,396
| +20% | +$1.3M |
|
|
XENT
1660
DELISTED
Intersect ENT, Inc
XENT
| $7.75M | ﹤0.01% |
572,062
-12,289
| -2% | -$166K |
|
1661
WESCO International
WCC
$10.4B
| $7.74M | ﹤0.01% |
220,380
+120,897
| +122% | +$4.24M |
|
1662
Central Garden & Pet Class A
CENTA
$2.03B
| $7.71M | ﹤0.01% |
285,275
+18,544
| +7% | +$501K |
|
|
UFS
1663
DELISTED
DOMTAR CORPORATION (New)
UFS
| $7.7M | ﹤0.01% |
364,832
+75,555
| +26% | +$1.6M |
|
1664
LGI Homes
LGIH
$1.39B
| $7.7M | ﹤0.01% |
87,412
-9,068
| -9% | -$798K |
|
1665
CNX Resources
CNX
$4.25B
| $7.69M | ﹤0.01% |
889,451
+114,358
| +15% | +$989K |
|
1666
Nuveen ESG 1-5 Year US Aggregate Bond ETF
NUSA
$32.8M
| $7.68M | ﹤0.01% |
300,000
| – | – |
|
1667
MillerKnoll
MLKN
$1.4B
| $7.68M | ﹤0.01% |
325,334
-36,721
| -10% | -$867K |
|
1668
ServisFirst Bancshares
SFBS
$4.57B
| $7.68M | ﹤0.01% |
214,612
-40,393
| -16% | -$1.44M |
|
1669
Visteon
VC
$3.4B
| $7.67M | ﹤0.01% |
112,029
-7,479
| -6% | -$512K |
|
1670
Rocket Pharmaceuticals
RCKT
$341M
| $7.65M | ﹤0.01% |
365,531
+66,754
| +22% | +$1.4M |
|
1671
Glaukos
GKOS
$4.75B
| $7.65M | ﹤0.01% |
199,093
+3,122
| +2% | +$120K |
|
|
BEAT
1672
DELISTED
BioTelemetry, Inc.
BEAT
| $7.64M | ﹤0.01% |
169,106
-28,263
| -14% | -$1.28M |
|
1673
Customers Bancorp
CUBI
$2.32B
| $7.59M | ﹤0.01% |
631,472
+121,703
| +24% | +$1.46M |
|
1674
Adeia
ADEA
$1.71B
| $7.55M | ﹤0.01% |
1,932,824
+523,610
| +37% | +$2.04M |
|
1675
HDFC Bank
HDB
$179B
| $7.52M | ﹤0.01% |
165,388
+155,967
| +1,656% | +$7.09M |
|